Literature DB >> 6406072

Treatment of the acute migraine attack--current status.

M Wilkinson.   

Abstract

The main treatment of the acute migraine attack remains sleep, sedation, an anti-nauseant and analgesics, and in some patients 1 or 2 mg of ergotamine tartrate. Drugs containing large amounts of caffeine should not be used. Absorption of drugs may be impaired in a migraine attack. Metoclopramide is probably the anti-emetic of choice because it is an effective anti-nauseant and promotes normal gastrointestinal activity. Domperidone has a similar action but is said not to go through the blood-brain barrier, so is less likely to cause extrapyramidal reactions. All drugs, including analgesics such as aspirin and paracetamol, are best given in a soluble or effervescent form. Where vomiting occurs early in the attack, suppositories may be indicated. Ergotamine tartrate is necessary in about one third of attacks and is best given by suppository or by inhalation. Doses higher than 2 mg per attack or 6 mg in one week may cause toxic symptoms, the early signs of which are headache, nausea, vomiting and a feeling of not being very well. The non-drug treatments of an acute attack include pressing on the temporal artery, hot and cold compresses and relaxation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406072     DOI: 10.1046/j.1468-2982.1983.0301061.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

1.  Intercepting migraine: results of early therapy with nonspecific and migraine-specific agents.

Authors:  Robert Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

2.  Napping behavior in adults with episodic migraine: a six-week prospective cohort study.

Authors:  Angeliki Vgontzas; Elizabeth Mostofsky; Kobina Hagan; Michael Rueschman; Murray A Mittleman; Suzanne M Bertisch
Journal:  Sleep       Date:  2022-03-14       Impact factor: 6.313

3.  The use of combination therapies in the acute management of migraine.

Authors:  Abouch Valenty Krymchantowski
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

Review 4.  Acute treatment of migraine. Breaking the paradigm of monotherapy.

Authors:  Abouch Valenty Krymchantowski
Journal:  BMC Neurol       Date:  2004-01-28       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.